These authors contributed equally to this work.
Association of HLA locus variant in Parkinson's disease
Article first published online: 29 OCT 2012
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Special Issue: Variant
Volume 84, Issue 5, pages 501–504, November 2013
How to Cite
Association of HLA locus variant in Parkinson's disease., , , , , , , , , , , , , .
The authors have no conflict of interest to declare.
- Issue published online: 17 OCT 2013
- Article first published online: 29 OCT 2012
- Accepted manuscript online: 20 OCT 2012 07:05AM EST
- Manuscript Revised: 17 SEP 2012
- Manuscript Accepted: 17 SEP 2012
- Manuscript Received: 8 JUL 2012
- National Medical Research Council
- Singapore Millennium Foundation
- Duke Graduate Medical School
- The University of Malaya. Grant Number: E000033 HIR-MOHE
- Parkinson's disease;
A variant (rs3129882) in the genome-wide association study (GWAS)-linked variant [in the human leukocyte antigen (HLA) gene region] has been reported to associate with an increased risk of Parkinson's disease (PD) in Caucasian population. Studies among Chinese are limited. To address this, we analysed rs3129882 in a total of 1312 subjects of Chinese ethnicity from independent Asian centers comprising of 675 controls and 637 PD cases. The rs3129882 variant was associated with a decreased risk in our ethnic Chinese PD patients. Logistic regression analysis taking into consideration variables of age, gender and race showed that allele A reduced the risk of PD via a dominant model [odds ratio (OR) = 0.77, 95% confidence interval (CI) = 0.62, 0.96, p = 0.018]. As HLA is a highly polymorphic region, it is possible that ethnic-specific effect or environmental agents may modulate the effect of this GWAS-linked locus in influencing the risk of PD.
Parkinson's disease (PD) is a progressive neurodegenerative disease which frequently leads to neurological disability. There have been a number of genes that have been associated with familial and sporadic PD, including LRRK2, PINK1, Parkin/Park2 . A recent genome-wide association study (GWAS) identified another possible genetic marker that is associated with PD among Caucasians, and this was particularly strong for men and for late-onset PD . This GWAS-linked single nucleotide polymorphism (SNP) is located in the human leukocyte antigen (HLA) gene on chromosome 6p21.3. The SNP rs3129882 in intron 1 of HLA-DRA has been shown to be most robustly associated with PD. HLA-DR is a major histocompatibility complex which has a role in immune responses and inflammation. The identification of rs3129882 highlights the links between PD and human immunity and inflammation, and potentially opens up a new avenue for therapeutic intervention.
Recent replication studies in other Caucasian populations have provided conflicting results [3, 4]. Interestingly, while the Caucasian cohort study examined by Hamza  found the minor G allele to be the susceptibility allele, Guo  reported the susceptibility allele to be the A allele in their Asian cohort. The HLA region is known to be polymorphic amongst different ethnic groups, and therefore the differences in minor alleles can be attributed to the polymorphic nature of this genomic region.
To address current limited information of this locus among ethnic Chinese and conflicting results among Caucasians, we examined the association between rs3129882 and PD among ethnic Chinese in two independent Asian centers.
Patients diagnosed to have PD by movement disorders neurologists at three Asian centers (two in Singapore and one in Malaysia) based on the UK Brain Bank criteria were recruited. Controls of similar age, gender and race examined by clinicians and those without any evidence of neurological diseases were also recruited for the study. Effort was taken to match these controls with the patients in terms of geographical region.
A total of 1312 ethnic Chinese subjects comprising of 675 controls and 637 PD cases were included in the study. Eighty cases and 57 controls have participated in a previous GWAS study . Genomic DNA was extracted from blood samples using standard protocols. Genotyping of rs3129882 was performed using TaqMan® SNP Genotyping Assay and TaqMan® genotyping Master Mix according to the manufacturer's standard protocol on a 96-well plate. Fluorescent signals of VIC- and FAM-probes were analysed at end point; allele call and genotypes were generated automatically in Applied Biosystems, Foster City, CA 7500 series Real-Time polymerase chain reaction (PCR) System. The thermal cycling conditions included 50°C for 2 min, 95°C for 10 min and 40 cycles of denaturing and anneal/extension reactions (92°C for 15 s and 60°C for 1 min). Sequencing was carried out to validate representative genotypes in selected samples.
Fisher's exact test was performed to verify the Hardy–Weinberg equilibrium (HWE) of rs3129882 among controls and the gender distribution between cases and controls. Odds ratio (OR) and 95% confidence interval (CI) were estimated to investigate the role of SNP in the development of PD by means of logistic regression. Then, the most suitable model was selected based on the relationship of OR1 (AA vs GG) and OR2 (AG vs GG) to reflect a biological model of gene effect. We assumed the disease allele is in complete linkage disequilibrium with rs3129882 and with the same allele frequency of 0.65. For a risk ratio of about 1.5, our study has about 80% power to achieve significance level of 0.05. ORs were also adjusted by age and gender to minimize their effects. All analyses were done using R version 2.11.1 (http://www.Rproject.org) and stata version 11.
A total of 1312 subjects that consisted of 675 controls and 637 cases were included in the analysis. Table 1 shows the demographic features of the cohort. The SNP rs3129882 was in HWE among controls verified by means of Fisher's exact test. The median age, together with range of controls and cases were 60.0 (29, 88) and 62.0 (21, 90) years, respectively. Logistic regression analysis taking variables such as age, gender and race into consideration showed that variant A reduced the risk of PD via a dominant model (OR = 0.77, 95% CI = 0.62, 0.96, p = 0.018; Table 2).
|Mean age (years)||67.2 (SD = ±9.80)||61.6 (SD = ±9.56)|
|Mean age of onset (years)||61.0 (SD = ±11.1)||NA|
|Gender, male %||57.2||51.2|
|Genotype||Cases (%)||Controls (%)||ORa||ORb|
|GA||260||321||0.74 (0.59, 0.94)||0.74 (0.58, 0.94)|
|AA||73||76||0.88 (0.61, 1.26)||0.87 (0.59, 1.27)|
|Common (G) allele||868||877||—||—|
|Minor (A) allele||406||473||—||—|
|Dominant model||—||—||0.77 (0.62, 0.96)||0.76 (0.61, 0.96)|
The rs3129882 variant at the GWAS-linked locus is the most widely assessed marker at the HLA-DRA region in relation to PD, though other variants have also been examined . Both HLA-DRA and HLA-DRB encode proteins that are referred to as class II HLA-DR antigens. The HLA-DRA expression level is correlated with rs3129882, even though rs3129882 is an intronic marker. The rs3129882 is not in high LD with any variant within the HLA-DRA region (r2 ≤ 0.8%) . It is possible that the variant may affect HLA mRNA splicing or gene expression.
The first report of this variant as a susceptibility factor was in PD by Hamza and colleagues, replication studies in Caucasian cohorts have produced inconsistent results (Table 3). It is also interesting to note that the minor alleles are reversed in Caucasians and Chinese. Guo reported the A allele to be a risk factor in late-onset, sporadic Chinese PD patients in Mainland China, while the result could not be replicated by Chiang and colleagues in Taiwan. In this study, we showed that the A allele reduces risk of developing PD among ethnic Chinese in Singapore and Malaysia. The minor allele frequency (MAF) of the A allele in the controls in Chiang's study was 0.368, in Guo's study 0.29 and in our dataset was 0.35. The MAF for this allele in the HapMap Han Chinese (China) database was 0.384. Therefore, it is possible that there was a selection bias of controls in the study by Guo. Although the distributions of alleles are different in different populations, the biological effect of each allele (A or G) might be same in different populations. Functional studies will need to be conducted to investigate the effect of the G and A alleles.
|Hamza et al. ||Caucasians (American of European ancestry) |
|Minor allele G |
|G allele increases risk of PD |
p = 2.9 × 10−8
|Edwards et al. ||Caucasian|
|Minor allele G||Borderline association |
p = 0.06
(as mentioned in Mata et al. )
|Mata et al. ||Spanish|
|Minor allele G |
|No association |
p = 0.88
|Simon-Sanchez et al. ||Caucasian (Dutch) |
|Not indicated||No association |
p = 0.312
|Chiang et al. ||Taiwanese |
|G allele |
|No association |
OR 0.94 for A allele
p = 0.446
|Guo et al. ||Chinese |
|G allele |
|A allele confers increased risk of |
PD, OR 1.37
No OR value reported
p = 0.016
et al. paper)
|Chinese (Mainland |
|G allele |
|No association |
p = 0.47
|Current study||Chinese |
|G allele |
|A allele reduces risk of PD |
p = 0.018
Although Chiang's study in Taiwan did not find any significant association with rs3129882, there was a trend toward a protective effect (OR = 0.94, p = 0.446), similar to our study findings . It is likely that the discrepant associations and minor/major allele differences among the same race are due to the highly polymorphic region of the HLA locus which may result in genetic variability that can be influenced by environmental or other gene–gene effects.
In conclusion, our case–control study showed a decreased risk of rs3129882 in our ethnic Chinese PD patients, instead of an increased risk. Our findings add to the understanding of the significance of the HLA region in association with PD in this ethnic group. With continued research into the HLA region and PD in ethnic Han Chinese communities throughout the world, it will become clear whether the protective effect is restricted to certain geographical regions or it represents the association in the Han Chinese as a whole. Our results will also provide impetus for further independent studies in other Chinese populations and comparisons with other Asian races to determine the exact modulating effect of this locus in PD.
We thank National Medical Research Council, Singapore Millennium Foundation, Duke Graduate Medical School (Estate of the Late Khoo Teck Puat) and the University of Malaya E000033 HIR-MOHE grant for their support.
The study has received approval from the relevant ethics committees and informed consent has been taken from every study subject.